Results of Annual General Meeting and Appointment of Jeremy Punnett to the Board of Directors

Pipeline update and final results for the year ended 31 January 2024

Lord David Prior Appointed as Chair of e-therapeutics’ Board of Directors

Proposed Fundraise of £28.9m and Cancellation

Business Update

Interim Results for the financial year 2023/2024
